Viewing Study NCT02287467


Ignite Creation Date: 2025-12-25 @ 12:53 AM
Ignite Modification Date: 2026-02-25 @ 8:25 PM
Study NCT ID: NCT02287467
Status: COMPLETED
Last Update Posted: 2019-11-14
First Post: 2014-11-06
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluating the Safety and Efficacy of Anti-Influenza Intravenous Hyperimmune Immunoglobulin (IVIG) in Adults Hospitalized With Influenza
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Organization Data

Organization:
Class: NIH
Study ID: INSIGHT 006: FLU-IVIG
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None NETWORK View